Arun Chockalingam
Papers
1
Total Citations
11
H-Index
1
About
Arun Chockalingam is a leading clinical researcher whose work centers on the comparative effectiveness of treatments for early-stage non-small cell lung cancer (NSCLC). His major contribution lies in advancing the evidence base for minimally invasive interventions, particularly through rigorous systematic reviews and network meta-analyses. His most cited work, a 2022 protocol comparing surgical resection, radiotherapy, and percutaneous thermal ablation for stage 1 NSCLC, has already garnered 11 citations, reflecting its critical role in shaping clinical decision-making for increasingly complex patient populations. By systematically evaluating these treatment modalities, Chockalingam addresses the pressing need to move beyond the traditional gold standard of surgery toward personalized, less invasive options. His research is notable for its methodological rigor and direct relevance to modern oncology, where patient comorbidity and advanced disease demand nuanced therapeutic strategies. Chockalingam’s work is essential reading for clinicians and researchers seeking to understand the evolving landscape of lung cancer treatment and the evidence supporting image-guided ablation as a viable alternative.
Research Focus
Key Achievements
Top Papers
- 1